000 | 01269 a2200325 4500 | ||
---|---|---|---|
005 | 20250516042809.0 | ||
264 | 0 | _c20120416 | |
008 | 201204s 0 0 eng d | ||
022 | _a1179-6901 | ||
024 | 7 |
_a10.2165/11590440-000000000-00000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZinser-Sierra, Juan W | |
245 | 0 | 0 |
_aUse of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009). _h[electronic resource] |
260 |
_bDrugs in R&D _c2011 |
||
300 |
_a101-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
650 | 0 | 4 | _aBevacizumab |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aColorectal Neoplasms _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNeoplasm Metastasis |
700 | 1 | _aRodríguez-Ramírez, Saúl | |
700 | 1 | _aVillalobos-Valencia, Ricardo | |
700 | 1 | _aRamírez-Márquez, Marcelino | |
773 | 0 |
_tDrugs in R&D _gvol. 11 _gno. 2 _gp. 101-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/11590440-000000000-00000 _zAvailable from publisher's website |
999 |
_c20933736 _d20933736 |